Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Epigenomic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Epigenomicmarket, defines the market attractiveness level of Epigenomic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Epigenomic industry, describes the types of Epigenomic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Epigenomic market and the development prospects and opportunities of Epigenomic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Epigenomic market in Chapter 13.
By Player:
Novartis
Thermo Fisher Scientific
Roche Diagnostics
Eisai
By Type:
Reagents
Kits
Instruments
Enzymes
Services
By End-User:
Oncology
Non Oncology
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Epigenomic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Epigenomic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Epigenomic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Epigenomic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Epigenomic Market Analysis and Outlook to 2022
-
7.1 Global Epigenomic Consumption (2017-2022)
-
7.2 United States Epigenomic Consumption (2017-2022)
-
7.3 Europe Epigenomic Consumption (2017-2022)
-
7.4 China Epigenomic Consumption (2017-2022)
-
7.5 Japan Epigenomic Consumption (2017-2022)
-
7.6 India Epigenomic Consumption (2017-2022)
-
7.7 South Korea Epigenomic Consumption (2017-2022)
8 Region and Country-wise Epigenomic Market Analysis and Outlook to 2028
-
8.1 Global Epigenomic Consumption Forecast (2022-2028)
-
8.2 United States Epigenomic Consumption Forecast (2022-2028)
-
8.3 Europe Epigenomic Consumption Forecast (2022-2028)
-
8.4 China Epigenomic Consumption Forecast (2022-2028)
-
8.5 Japan Epigenomic Consumption Forecast (2022-2028)
-
8.6 India Epigenomic Consumption Forecast (2022-2028)
-
8.7 South Korea Epigenomic Consumption Forecast (2022-2028)
9 Global Epigenomic Market Outlook by Types and Applications to 2022
-
9.1 Global Epigenomic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Reagents Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Kits Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Instruments Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Enzymes Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Services Consumption and Growth Rate (2017-2022)
-
9.2 Global Epigenomic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non Oncology Consumption and Growth Rate (2017-2022)
10 Global Epigenomic Market Outlook by Types and Applications to 2028
-
10.1 Global Epigenomic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Reagents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Kits Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Instruments Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Enzymes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Services Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Epigenomic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non Oncology Consumption Forecast and Growth Rate (2022-2028)
11 Global Epigenomic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Epigenomic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Epigenomic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Epigenomic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Epigenomic Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Epigenomic Product and Service
-
14.2 Thermo Fisher Scientific
-
14.2.1 Thermo Fisher Scientific Company Details
-
14.2.2 Thermo Fisher Scientific Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Thermo Fisher Scientific Epigenomic Product and Service
-
14.3 Roche Diagnostics
-
14.3.1 Roche Diagnostics Company Details
-
14.3.2 Roche Diagnostics Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Diagnostics Epigenomic Product and Service
-
14.4 Eisai
-
14.4.1 Eisai Company Details
-
14.4.2 Eisai Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Epigenomic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Epigenomic
-
Figure Epigenomic Picture
-
Table Global Epigenomic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epigenomic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epigenomic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Epigenomic Consumption by Country (2017-2022)
-
Figure United States Epigenomic Consumption and Growth Rate (2017-2022)
-
Table Europe Epigenomic Consumption and Growth Rate (2017-2022)
-
Figure China Epigenomic Consumption and Growth Rate (2017-2022)
-
Figure Japan Epigenomic Consumption and Growth Rate (2017-2022)
-
Figure India Epigenomic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Epigenomic Consumption and Growth Rate (2017-2022)
-
Figure Global Epigenomic Consumption Forecast by Country (2022-2028)
-
Figure United States Epigenomic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Epigenomic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Epigenomic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Epigenomic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Epigenomic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Epigenomic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Reagents Consumption and Growth Rate (2017-2022)
-
Figure Global Kits Consumption and Growth Rate (2017-2022)
-
Figure Global Instruments Consumption and Growth Rate (2017-2022)
-
Figure Global Enzymes Consumption and Growth Rate (2017-2022)
-
Figure Global Services Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Non Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Reagents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kits Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Instruments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzymes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Epigenomic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Epigenomic Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Epigenomic Product and Service
-
Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Epigenomic Product and Service
-
Table Roche Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Roche Diagnostics Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Diagnostics Epigenomic Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Epigenomic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Epigenomic Product and Service
-
